Company
AnchorDX
引领精准医疗，造福千家万户
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Guangzhou, China
- Founded
- 2015
- Legal name
- 广州市基准医疗有限责任公司
Claim, correct or request removal
Record updated 28 September 2026
About
基准医疗 (Jizhun Medical) was founded in 2015 on Guangzhou International Bio Island, with R&D centers in both China and the United States. It is committed to the R&D, production and sales of early cancer screening and diagnosis products using internationally advanced methylation high-throughput sequencing technology, and also provides the corresponding testing services.
Funding snapshot
- Total raised
- $83MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Series C, $40M2021
Funding rounds
- Series C
- $40M2021, Company stated
- Series B
- $38M2017, Company stated
- Series A
- $5M2015, Company stated
Products
- Other
- 尿立检
- Other
- 泌益检（UriFind）
- Other
- 费影检（Pulmoinsight）
- Other
- 费益检（PulmoSeek Plus）
- Other
- 费镜检（PulmoPath）
Loading relationship preview